The missing piece in succession planning.
A succession plan names the people who can do the job. It rarely records whether those people are well enough to hold it. CEREVITY gives boards and CHROs a confidential, private-pay clinical channel for the leaders their plan depends on, before the transition and through the first year after it.
Succession planning identifies and develops the leaders who come next, but most plans model capability, tenure, and timing without asking whether the successor is well. Boards and CHROs increasingly pair the plan with confidential, private-pay therapy for named successors, so readiness is judged on durability and judgment rather than on credentials and title alone.
What CEREVITY is.
A nationwide network of independent licensed clinicians, offered as a confidential leadership benefit.
CEREVITY is a nationwide network of independent licensed clinicians providing private-pay therapy by secure telehealth across all 50 states. It is not an app, not a coaching marketplace, and not an employee assistance program. Each leader is matched by hand to a clinician experienced with high-responsibility roles, and keeps that clinician for as long as the work continues.
For a board or a CHRO, the mechanics are simple to reason about. Care is private pay with no insurance claim filed, so nothing routes through the company health plan and no claim record is created. The benefit sits above the existing employee assistance program rather than replacing it, and it is scoped to the small number of people whose continuity the succession plan actually rests on.
Most organizations arrive here from one of two directions. Some are building the leadership tier of a broader executive mental health benefit for companies, and want the successor bench included from the start. Others are already inside a transition and need structured support through a CEO transition for the incoming and the outgoing leader at the same time.Why succession planning misses this.
The plan models capability and timing. It does not model the person carrying them.
A succession plan is an inventory of readiness: who could step up, on what timeline, with which gaps closed by which development assignment. Every one of those columns describes capability. None of them describes state. A leader can be the strongest candidate on the grid and simultaneously be running on four hours of sleep, avoiding the one conversation that matters, and quietly deciding that the larger job is not worth what it would cost at home. Senior leaders are also markedly slow to seek care, so none of that reaches anyone whose job it is to notice.
The volume of transitions makes the gap expensive rather than theoretical, and the cost of executive turnover is carried by the organization, not by the plan.
CEO exits were announced at US companies in 2025, including a record 446 at public companies. Every one of them was a succession plan meeting reality. Source: Challenger, Gray and Christmas, 2025 CEO Turnover Report, February 2026.
Two failure modes follow. The successor who is not well when named performs to the role's floor rather than its ceiling, and the board reads the shortfall as a capability miss. Or the successor declines the seat, or takes it and leaves inside eighteen months, and a plan that took three years to build resets to zero. Both are versions of key person risk, and neither is visible in the succession grid until it has already happened.
Readiness is also thinner than the paperwork suggests. In a 2026 survey of 250 board directors and chief executives, half said succession planning had started too late during their last transition, only 15 percent said their organization did a very strong job preparing a first-time chief executive, and only 10 percent said the new chief executive was already fully trusted by the board.
Source · Korn Ferry, CEO and board succession study, survey of 250 board directors and chief executives, April 2026, published July 2026.
A standard employee assistance program does not close that gap. It was designed for high-volume, short-term support across an entire workforce, and the people named in a succession plan will not route something this sensitive through a company channel that human resources administers. The reasoning is set out at length in our note on why executives do not use your EAP.
What successors actually bring to the work.
The presenting issues behind the readiness rating, in the language of the role.
Named and watched
Being identified as the successor changes the job before the title does. Every meeting becomes an audition, and the ordinary permission to be uncertain out loud disappears. Sustained evaluation of this kind is where high-stakes anxiety takes hold.
The competence question
Strong candidates rarely feel like the obvious choice from the inside. The gap between how the board sees them and how they see themselves widens under scrutiny, and imposter syndrome is the most common presenting issue in this group.
Nowhere to say it
The successor cannot confide in the incumbent, in the peers who were passed over, or in the board that will vote. That is a textbook case for leadership isolation therapy, and it arrives with the nomination.
Two jobs at once
Successors run their current role at full load while preparing for a larger one, usually with no reduction anywhere. The volume of consequential calls compounds, and decision fatigue degrades judgment quietly before anyone names it.
Running hot before the handover
Development assignments stack on top of an already full seat, and the strain is read as commitment. Executive burnout therapy exists to catch the pattern in the year before the transition rather than the year after it.
The mind that will not stop
Anticipating a role you have not yet held is an unusually effective way to lose sleep. Chronic hyper-vigilance erodes the recovery that decision quality depends on, and it is often the earliest visible signal that a successor is running past their limit.
Peers who were not chosen
A succession decision reshapes every lateral relationship on the leadership team at once. The successor inherits colleagues who competed for the seat and now report into it, and the loss of easy peer support usually goes unspoken on both sides.
What the transition costs at home
Relocations, travel, and a step change in visibility land on a household that did not get a vote. Couples therapy is part of the network because the strain of a promotion is frequently first visible there.
The plan told us he was ready. It could not tell us he was running on empty, and that was the only thing that turned out to matter.
Session formats built for a transition calendar.
Three lengths, no rigid weekly slot.
The steady cadence of ongoing therapy. Most clients spend most of their care in 50-minute sessions.
For work that needs more room than a standard hour can hold. See 90-minute sessions.
For work that needs uninterrupted time to reach resolution. See 3-hour therapy intensives.
Care is delivered in 50-minute, 90-minute, and 3-hour sessions by secure telehealth, nationwide. A successor moving through board meetings, investor days, and site visits can do concentrated work in a single longer block rather than defending a standing weekly appointment that travel will break, and the longest format is used most often at the two pressure points of a transition, the weeks after the announcement and the first quarter in seat. Continuity is preserved because the leader keeps the same clinician throughout, and modality is matched at intake rather than assigned.
Protect the people the plan depends on.
A confidential conversation about a leadership-tier benefit takes one call. Nothing about it touches the company health plan or the succession file.
Start a partnership conversationHow a named successor is matched.
Every leader is matched by hand, not by an algorithm running against an intake form. Clinicians are selected for experience with high-responsibility roles, and the match is reviewed by CEREVITY's clinical leadership before a first session is scheduled.
The eligible individual submits a confidential intake form covering presenting issues, modality preference, professional context, and scheduling parameters. Operated by CEREVITY directly, not by a broker.
Intake is reviewed by CEREVITY's clinical leadership against the network's active capacity, current licensure footprint, and modality availability. This is the step that does not exist in an EAP.
A specific clinician is matched to the named successor, who receives the match with the clinician's profile, modality, and credentials, plus a direct online scheduling link.
Scheduling runs directly through CEREVITY infrastructure with no phone handoff. First sessions are typically scheduled within 5 to 10 business days of the match.
Care continues on the cadence the clinical work requires, in 50-minute, 90-minute, or 3-hour sessions, without an employer-imposed session cap.
Capability comparison for succession planning.
An evaluation framework on the dimensions that matter when scoping a leadership-tier offering. All three models have a place; they are built for different populations, which is the argument for running a leadership-tier channel alongside the EAP rather than as a replacement for it.
| Dimension | Typical EAP | Executive-tier platform | CEREVITY |
|---|---|---|---|
| Network model | Broker layer between employer and contractor roster | Single-vendor platform, W-2 or contracted pool | Independent clinical network with direct relationships |
| Clinician assignment | First contractor to reply with availability | Algorithmic matching on intake-form inputs | Clinical review by network leadership |
| Intake and scheduling | Phone handoff to the clinician's line | App-based intake and scheduling | Network-operated intake, direct online scheduling |
| Session formats | Standard 50-minute, capped session counts | Standard 45 to 50-minute sessions | 50-minute, 90-minute, and 3-hour formats, no cap |
| Clinical scope | Acute, broadly applicable concerns | Workforce-wide, executive tier as an upsell | Built around the presenting issues of named successors |
| Modality fit | Generalist talk therapy | Generalist therapy with some specialty | CBT, DBT, psychodynamic, IFS, matched at intake |
| Reach | National via roster density | National telehealth, roster variance | All 50 states via telehealth |
| Payment model | Employer-sponsored, in network | Per-employee-per-month seat pricing | Private pay, out of network, partnership agreement |
| Board visibility | Aggregate, broker-mediated | Vendor dashboards with engagement metrics | Administrative reporting only |
| Right fit for | Workforce-wide acute support | Mid-tier ongoing care with an executive add-on | succession planning, end to end |
If you are running a formal evaluation, our notes on what to look for in a private therapy provider cover the procurement side in detail, including scoping, clinical governance, and what a partnership agreement should specify before it goes live.
What the board sees, and what it does not.
A successor will not use a channel that could inform the decision about them. CEREVITY is built so that engaging with it creates no visibility into their care, with no record the employer sees and no report of any kind back to the board or to human resources.
- Confirmation that contracted services were provided to eligible individuals.
- Aggregate utilization at the partnership level, where contractually appropriate.
- Invoicing and eligibility reconciliation.
- Nothing tied to a specific named named successor's clinical content.
- Whether a specific named named successor has scheduled, attended, or engaged.
- What clinical issues are being addressed, or which clinician is assigned.
- Session notes, treatment plans, or diagnostic information.
- Any attendance detail at the individual level.
Clinicians are independent licensed professionals operating under their own licensure and the confidentiality and privacy obligations that attach to it. Protected health information is held within the clinical infrastructure, and the agreements governing it are defined in writing before the partnership goes live. Our notice of privacy practices and privacy policy are published in full.
Clinical records, session content, and individual engagement data sit inside the clinical platform. The administrative layer the partner interacts with is structurally separate from the clinical layer.
Eligibility lists are maintained on the partner side and confirmed at the point of intake. Administering eligibility does not require the partner to receive clinical information back.
A Business Associate Agreement is executed where the partnership structure requires it, and whether one applies is a determination made with counsel rather than assumed. The partnership agreement defines the administrative reporting scope in writing before anything goes live. See also our terms of service.
Leaders frequently ask about downstream exposure before they will engage at all. The question that comes up most is whether therapy shows up on a background check, which matters more than usual to someone whose next role carries a public filing. It is answered directly on our site.
What the first 30 days look like.
The hardest part of a leadership-tier partnership is not the contract. It is the period between signature and the first named successor in care.
A 60-minute kickoff with your team and CEREVITY's partnership lead. We confirm the partnership shape, the eligibility model, the administrative reporting scope, and the internal owner. The BAA, where applicable, is executed.
Your team provides the eligible-individual list. CEREVITY confirms it against the network and establishes the verification path at intake. Only eligibility confirmation flows forward.
CEREVITY provides a confidential, leadership-tier comms template explaining the benefit, the privacy posture, and how to access intake. It is written to be received without stigma.
Eligible individuals begin intake on their own cadence. First sessions are typically scheduled within 5 to 10 business days. By day 30 the partnership is operational and a quarterly review cadence is in place.
The business case for the board.
Continuity, decision quality, and the ability to recruit a bench are the levers, and the succession plan already runs on all three.
Continuity of the bench
A succession plan is only an asset if the named people are still there when it is needed. Confidential clinical care is one of the few interventions that reaches the leaders least likely to ask for help, and the link between retention and mental health is where most of the return sits. Losing a named successor does not cost one hire; it costs the years of development that went into them.
Decision quality through the transition
Judgment, focus, and pace degrade under chronic unmanaged strain, and the effect is measurable long before anyone steps back. A transition is the worst possible window in which to absorb that, because the new leader's first two quarters set the board's read on the whole appointment.
Credibility with the people you are recruiting
Candidates for senior seats ask what support exists at the top, and the honest answer is usually nothing beyond a coach with a reporting line. Offering confidential clinical care through a dedicated CEO therapist practice signals that the organization treats its leaders as long-term assets, which matters both to internal successors and to the external candidates you benchmark them against.
Questions boards and CHROs ask first.
What is succession planning?
Succession planning is the process of identifying and developing the people who could take over critical leadership roles, so the organization is not starting from zero when a seat opens. In practice it covers the chief executive and the executive team, with a readiness horizon attached to each candidate. Family enterprises run a version of the same exercise, which is why succession work inside family offices carries the same pressures with fewer places to put them.
How does mental health affect leadership succession?
It affects both halves of the plan. A successor under sustained unmanaged strain performs below their capability, which the board tends to read as a selection error rather than a state, and a successor who is burned out at the moment of the offer may decline the role or leave shortly after taking it. Because succession plans record capability and timing but not condition, neither outcome is predictable from the document itself.
How do you retain successors once they are named?
Retention of a named successor depends on the interval between the naming and the seat being survivable. That means a realistic load, a genuine sponsor, and somewhere to take the pressure that is not the board and not the incumbent. Boards that handle this well tend to scope the support at the same meeting that confirms the shortlist, rather than waiting for the transition to begin.
Is this coaching or therapy?
It is therapy, delivered by licensed clinicians, and it is deliberately distinct from executive coaching. Coaching addresses performance and frequently reports back to a sponsor. Therapy is confidential clinical care with no stakeholder except the leader. The distinction is set out in our comparison of executive counseling and executive coaching, and many leaders use both for different purposes.
Which leaders would the benefit cover?
Scope is defined in the partnership agreement. Most organizations start with the chief executive, the named successors on the plan, and the executives running the transition, then extend to the wider leadership team over time. The benefit is deliberately narrow so it stays leadership-tier and so utilization is high enough to matter. You can scope it in a first call through the get started page.
Will the board or HR see who uses it?
No. Care is private pay, so no insurance claim is filed and nothing routes through the company health plan. There is no claim record for a benefits administrator, an insurer, or the board to access, and CEREVITY provides no individual reporting of any kind. Sessions remain between the leader and the licensed clinician, who is bound by their own licensure confidentiality obligations.
What does it cost the organization?
Structure is agreed in the partnership conversation and depends on how many leaders are covered and how wide the access is. CEREVITY is a private-pay network with transparent fees and no insurance-driven surprises in the accounting. Standard individual rates are published on our pricing page.
How do we begin?
Start a partnership conversation using the form on this page, by phone at (562) 295-6650, or through the contact page. A member of CEREVITY's clinical leadership will follow up directly and confidentially to scope a benefit that fits the plan you already have.
Start a partnership conversation.
Tell us about the plan and the leaders inside it. A member of CEREVITY's clinical leadership will follow up directly and confidentially.
Further reading and related partnerships.
Research, clinical writing, and the other places CEREVITY supports leadership continuity.
Research and reports
For boards and CHROs
Clinical writing
A note on sources.
CEO exit counts are drawn from the 2025 CEO Turnover Report published by Challenger, Gray and Christmas in February 2026, which tracks announced chief executive departures at US companies and recorded 2,032 exits in 2025 against 2,221 in 2024, with a record 446 at public companies. Succession readiness figures come from a Korn Ferry study of 250 board directors and chief executives surveyed in April 2026 and published in July 2026. The wider pattern of leaders considering an exit from leadership itself is documented in the DDI Global Leadership Forecast 2025, a survey of 10,796 leaders, in which 40 percent of stressed leaders reported having considered leaving a leadership role to protect their wellbeing. Figures are reported as published and are not adjusted. CEREVITY research referenced on this page is collected in our knowledge base.